Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy

This study has been completed.
Information provided by (Responsible Party):
Neuraltus Pharmaceuticals, Inc. Identifier:
First received: August 11, 2009
Last updated: September 26, 2011
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 26, 2011